These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 19432844)

  • 1. Cyclo-oxygenase-2 expression in photon-radiated and non-radiated uveal melanomas.
    Suesskind D; Paulsen F; Buchgeister M; Spitzer B; Rohrbach JM; Bartz-Schmidt KU; Spitzer MS
    Acta Ophthalmol; 2010 Aug; 88(5):582-7. PubMed ID: 19432844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of COX-2 and prognostic outcome in uveal melanoma.
    Cryan LM; Paraoan L; Hiscott P; Damato BE; Grierson I; Gray D; Farrell M; Doherty GA; Fitzgerald DJ; O'Brien C
    Curr Eye Res; 2008 Feb; 33(2):177-84. PubMed ID: 18293189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase-2 expression in human irradiated uveal melanomas.
    Ozdal PC; Callejo S; Caissie AL; Edelstein C; Bakalian S; Vianna RN; Burnier MN
    Int Ophthalmol; 2008 Feb; 28(1):1-6. PubMed ID: 17603773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A histologic study (including DNA quantification and Ki-67 labeling index) in uveal melanomas after brachytherapy with ruthenium plaques.
    Schilling H; Sehu KW; Lee WR
    Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2081-92. PubMed ID: 9331272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible effects of radiobiological parameters on metastatic spread of uveal melanomas treated with 106Ru plaques.
    Kleineidam M; Guthoff R
    Ger J Ophthalmol; 1994 Jan; 3(1):22-5; discussion 25-6. PubMed ID: 8142877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma.
    Blom DJ; Luyten GP; Mooy C; Kerkvliet S; Zwinderman AH; Jager MJ
    Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1865-72. PubMed ID: 9286277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COX-2 expression in malignant melanoma: a novel prognostic marker?
    Becker MR; Siegelin MD; Rompel R; Enk AH; Gaiser T
    Melanoma Res; 2009 Feb; 19(1):8-16. PubMed ID: 19430402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of PCNA and Ki-67 in posterior uveal melanomas in adults.
    Proniewska-Skretek E; Dziecioł J; Zalewska R; Mariak Z
    Rocz Akad Med Bialymst; 2004; 49 Suppl 1():79-81. PubMed ID: 15638382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumoral forkhead box P3-positive regulatory T cells predict poor survival in cyclooxygenase-2-positive uveal melanoma.
    Mougiakakos D; Johansson CC; Trocme E; All-Ericsson C; Economou MA; Larsson O; Seregard S; Kiessling R
    Cancer; 2010 May; 116(9):2224-33. PubMed ID: 20209608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MMP-9 is predominantly expressed in epithelioid and not spindle cell uveal melanoma.
    El-Shabrawi Y; Ardjomand N; Radner H; Ardjomand N
    J Pathol; 2001 Jun; 194(2):201-6. PubMed ID: 11400149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetics of uveal melanoma: a 7-year clinical experience.
    Damato B; Duke C; Coupland SE; Hiscott P; Smith PA; Campbell I; Douglas A; Howard P
    Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible implications of MCAM expression in metastasis and non-metastatic of primary uveal melanoma patients.
    Beutel J; Wegner J; Wegner R; Ziemssen F; Nassar K; Rohrbach JM; Hilgers RD; Lüke M; Grisanti S
    Curr Eye Res; 2009 Nov; 34(11):1004-9. PubMed ID: 19958117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The potential for organ-preserving treatment in large uveal melanoma].
    Terent'eva LS; Fokin VP
    Oftalmol Zh; 1989; (6):338-41. PubMed ID: 2622597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of cyclo-oxygenase-2 is correlated with high intratumoral microvessel density and low apoptotic index in human esophageal squamous cell carcinomas.
    Kase S; Osaki M; Honjo S; Adachi H; Tsujitani S; Kaibara N; Ito H
    Virchows Arch; 2003 Feb; 442(2):129-35. PubMed ID: 12596063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early expression of cyclo-oxygenase-2 during sporadic colorectal carcinogenesis.
    Hao X; Bishop AE; Wallace M; Wang H; Willcocks TC; Maclouf J; Polak JM; Knight S; Talbot IC
    J Pathol; 1999 Feb; 187(3):295-301. PubMed ID: 10398082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival after proton-beam irradiation of uveal melanomas.
    Kodjikian L; Roy P; Rouberol F; Garweg JG; Chauvel P; Manon L; Jean-Louis B; Little RE; Sasco AJ; Grange JD
    Am J Ophthalmol; 2004 Jun; 137(6):1002-10. PubMed ID: 15183783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term results of cobalt 60 curietherapy for uveal melanoma].
    Bacin F; Kwiatkowski F; Dalens H; Rozan R; Gagyi S; Donnarieix D; Bard JJ; Robert JL
    J Fr Ophtalmol; 1998 May; 21(5):333-44. PubMed ID: 9759427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
    Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
    Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of patients and metastatic and local recurrent tumor growth in malignant melanoma of the uvea after ruthenium plaque radiotherapy.
    Summanen P; Immonen I; Heikkonen J; Tommila P; Laatikainen L; Tarkkanen A
    Ophthalmic Surg; 1993 Feb; 24(2):82-90. PubMed ID: 8446359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.